NeoCardioLab

NeoCardioLab Application

Veröffentlicht von: gabriel altit

Beschreibung

The NeoCardioLab is a research laboratory interested in clinical and epidemiological neonatal cardiovascular research, as well as education in neonatal hemodynamics. The principal investigator of the NeoCardioLab is Dr. Gabriel Altit from the Montreal Children’s Hospital (at McGill University). On the NeoCardioLab website, we have made available for the learners a whole array of content (clips, videos, presentations, reading material, articles, etc.) as a learning opportunity on echocardiography (2D and 3D), TnECHO (targeted neonatal echocardiography), point of care ultrasound (POCUS) and near infrared spectroscopy (NIRS). You will find on the website, our comprehensive “Atlas” for the expected normal complete neonatal echocardiography (with clips of various views and explanations), as well as clips for selected congenital heart defects. Our training modules are: on NIRS in the neonatal intensive care unit, as well as on POCUS/TnECHO. We offer modules on TnECHO (Targeted Neonatal Echocardiography; with clips outlining all the views and measurements, pulmonary hypertension, PDA, normative values, etc.), POCUS (as well as the example of the use of a hand-held device and how to obtain views) and Congenital Heart defects, as well as modules on Strain/Speckle Tracking and Near Infrared Spectroscopy. We also now host the Neonatal NIRS consortium page and all the recordings of their webinars.
Please feel free to navigate the app and use it for training purposes and as a resource to complement your other learning materials. We are constantly updating the website and adding new content. You will also find information on the McGill University Neonatal Hemodynamics Clinical Research training program, if you are interested. Our research uses conventional and advanced echocardiography (speckle-tracking echocardiography on 2D and 3D acquisitions) to better understand the cardiovascular adaptation of newborns with various conditions (such as: prematurity, bronchopulmonary dysplasia, congenital heart defect, congenital diaphragmatic hernia, omphalocele and hypoxic ischemic encephalopathy). We also study cohorts of patients once they have graduated the neonatal intensive care unit (in neonatal follow-up, in the pediatric clinics, as well as during adulthood). Please feel free to contact us if you have questions or suggestions: [email protected]. We also have Twitter (@CardioNeo) and Instagram (@NeoCardioLab).
Ausblenden Mehr anzeigen...

Screenshots

NeoCardioLab Häufige Fragen

  • Ist NeoCardioLab kostenlos?

    Ja, NeoCardioLab ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist NeoCardioLab seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet NeoCardioLab?

    NeoCardioLab ist kostenlos.

  • Wie hoch ist der Umsatz von NeoCardioLab?

    Um geschätzte Einnahmen der NeoCardioLab-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Kuwait noch nicht bewertet.
Bewertungsverlauf

NeoCardioLab Bewertungen

Keine Bewertungen in Kuwait
Die App hat noch keine Bewertungen in Kuwait.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

NeoCardioLab Installationen

Letzte 30 Tage

NeoCardioLab Umsatz

Letzte 30 Tage

NeoCardioLab Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von NeoCardioLab mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.